Related Experiment Videos
The preoperative cardiovascular evaluation of the intermediate-risk patient: new data, changing strategies
David H Wesorick1, Kim A Eagle
1Division of General Medicine, Department of Internal Medicine, University of Michigan, USA. davidwes@umich.edu
Insights
Intermediate-risk patients undergoing surgery need careful cardiac risk assessment. Management should involve clinical tools for stratification, selective noninvasive testing, and optimized medical therapy, including beta-blockers.
Area of Science:
- Cardiology
- Perioperative Medicine
- Cardiac Surgery
Background:
- Intermediate-risk patients lack severe heart disease but have predictors of adverse cardiovascular events.
- Managing these patients involves complex decisions regarding cardiac testing and interventions.
- Current evidence guides optimal perioperative cardiovascular risk management.
Purpose of the Study:
- To review evidence for managing intermediate-risk preoperative patients.
- To provide recommendations for cardiac testing and intervention selection.
- To optimize perioperative cardiovascular outcomes in this patient group.
Main Methods:
- Review of current evidence and clinical guidelines.
- Analysis of data regarding noninvasive and invasive cardiac testing.
- Evaluation of the role of coronary revascularization and medical therapy.
Main Results:
- Clinical tools like the Revised Cardiac Risk Index are essential for risk stratification.
- Noninvasive testing is indicated for patients with multiple risk predictors or modifying factors.
- Preoperative coronary revascularization does not consistently reduce perioperative risk in stable coronary artery disease.
Conclusions:
- Intermediate-risk patients require identification and stratification using validated clinical tools.
- Noninvasive cardiac testing should be judiciously applied based on risk factors.
- Optimized medical therapy, including beta-blockers, is crucial for managing these patients.
Abstract:
The intermediate-risk preoperative patient can be defined as a patient without severely symptomatic or unstable heart disease who, nonetheless, has clinical predictors of adverse perioperative cardiovascular events. Newer data have created an awareness of competing considerations in managing these patients. There is still debate about how to appropriately select patients for noninvasive cardiac testing, invasive coronary testing, coronary revascularization, beta-blockers, or a combination of these. In this article, we review the evidence pertaining to these issues. We conclude that intermediate-risk preoperative patients are best managed by an approach that emphasizes the following points: intermediate-risk patients should be identified and risk stratified using a clinical tool (eg, the Revised Cardiac Risk Index); noninvasive cardiac testing should be reserved for those patients with multiple clinical predictors of risk or the presence of other modifying factors; preoperative coronary revascularization does not appear to reduce perioperative risk in patients with significant but stable coronary artery disease; and medical therapy should be optimized for these patients, including the application of beta-blockers in all intermediate-risk patients that do not have contraindications.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Coronary Artery Disease IV: Preventive Measures
Cardiac Catheterization I: Pre-Procedure Overview
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care